Philip Morris International Inc.


Latest Trade






Today's Range




52 Week Range




As of on the New York Stock Exchange ∙ Minimum 15 minute delay


Previous Close
3M AVG Volume
Today's High
Today's Low
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Forward P/E
Dividend (Yield %)

Next Event

Dividend For PHMO34.SA - 3.2362 BRL

Latest Developments


Philip Morris International Inc Posts 2021 Q3 Reported Diluted EPS Of $1.55

Philip Morris International Closes New USD 2.5 Billion 5-Year Business Transformation-Linked Credit Facility

Philip Morris Announces Satisfaction Of Japanese Antitrust Condition For Vectura Deal


About Philip Morris International Inc.

Philip Morris International Inc. is a holding company. The Company is engaged in the manufacture and sale of cigarettes, as well as smoke-free products, electronic devices and accessories, and other nicotine-containing products in markets outside the United States of America. Its segments include European Union Region (EU); Eastern Europe Region (EE); Middle East & Africa Region (ME&A); South & Southeast Asia Region (S&SA); East Asia & Australia Region (EA&A), and Latin America & Canada Region (LA&C). Its portfolio of international and local brands is led by Marlboro. Its other cigarette brands include Bond Street, Chesterfield, L&M, Lark and Philip Morris. It owns various local cigarette brands, such as Dji Sam Soe, Sampoerna A and Sampoerna U in Indonesia, and Fortune and Jackpot in the Philippines. Its IQOS smoke-free product brand includes heated tobacco and nicotine-containing vapor products. It also develops a pipeline of inhaled therapeutics and respiratory drug delivery.



Contact Info

120 Park Ave



United States


Executive Leadership

Andre Calantzopoulos

Executive Chairman of the Board

Jacek Olczak

Chief Executive Officer

Emmanuel Babeau

Chief Financial Officer

Drago Azinovic

President - Middle East and Africa Region and PMI Duty Free

Frederic De Wilde

President - European Union Region

Key Stats

2.26 mean rating - 19 analysts
Revenue (MM, USD)
















Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)

Latest News

Latest News

Philip Morris seals deal for UK's Vectura despite health group concerns

Cigarette maker Philip Morris (PMI) clinched its 1.1 billion-pound takeover of asthma inhaler maker Vectura on Thursday, winning the support of the British company's shareholders despite the concerns of health professionals.

Philip Morris seals deal to buy Vectura with 75% of shares tendered

Cigarette maker Philip Morris International (PMI) said on Thursday it had received about 75% of Vectura shares from shareholders as part of a public tender offer process to acquire the British company.

Philip Morris gets over a fifth of Vectura shares in takeover tender offer

Cigarette maker Philip Morris International (PMI) said on Wednesday shareholders holding 22.61% of Vectura shares had tendered their stock to the tobacco group as part of its deal to buy the asthma drug maker for 1.1 billion pounds ($1.51 billion).

Philip Morris buys 22.61% stake of target Vectura in market purchase

Tobacco major Philip Morris International said on Wednesday it has bought 22.61% of its acquisition target and maker of asthma drug inhalers Vectura in a market purchase. (Reporting by Aby Jose Koilparambil in Bengaluru; editing by Uttaresh.V)

Vectura tussle chips away at money’s winning might

Stakeholder capitalists like to shout. In the case of Philip Morris International’s offer for inhaler maker Vectura, the volume didn’t make much difference. PMI’s deep pockets prevailed over revulsion from health charities and a handful of investors at Big Tobacco looking...

UK's Vectura bows to sweetened 1.1 billion stg Philip Morris offer

Cigarette maker Philip Morris won the support of Vectura for its 1.1 billion pound ($1.5 billion) takeover offer for the inhaled treatments maker after outbidding private equity firm Carlyle, the British company said on Thursday.

No auction for Vectura as Carlyle declares $1.3 billion takeover bid final

The takeover battle between tobacco giant Philip Morris and private equity firm Carlyle for inhaled treatments maker Vectura will not be heading to the auction ring on Wednesday after Carlyle said it will not raise its bid.

Philip Morris, Carlyle could fight it out for UK's Vectura in auction ring

The takeover battle for drugmaker Vectura will enter a rare head-to-head auction process if private equity group Carlyle and tobacco giant Philip Morris do not make final bids by Tuesday, according to a British regulator.

Britain's takeover regulator intervenes in battle for drugmaker Vectura

Britain's takeover regulator said on Monday it would launch an auction process for Vectura if its suitors Carlyle Group and Philip Morris don't make final bids for the London-listed drugmaker by Tuesday.

Philip Morris lifts bid for UK's Vectura to 165 pence per share

Philip Morris has raised its bid for British drugmaker Vectura to 165 pence ($2.29) per share, the tobacco company said on Sunday.

UK's Vectura takeover battle heats up as Carlyle outbids Philip Morris

Private equity firm Carlyle Group on Friday outbid tobacco company Philip Morris in the takeover battle for Vectura, offering to buy the British drugmaker for about 958 million pounds ($1.3 billion).

Philip Morris to end Marlboro cigarette sales in UK within a decade

Tobacco group Philip Morris International will stop selling Marlboro cigarettes in Britain within a decade, its chief executive told the Daily Mail...

British minister asks for monitoring of Vectura's proposed takeover by Philip Morris -The Times

British Business Minister Kwasi Kwarteng has asked officials to monitor drugmaker Vectura Group PLC's proposed takeover by U.S. tobacco group Philip Morris International Inc, the Times newspaper reported

Cigarette maker Philip Morris to buy UK producer of respiratory treatments

Tobacco group Philip Morris International agreed on Friday to buy Vectura for 1.05 billions pounds ($1.44 billion), giving the U.S. firm access to the British drugmaker's respiratory ailment treatments and inhaling device technology.

Philip Morris to buy UK's Vectura for $1.44 billion

Cigarette maker Philip Morris International Inc said on Friday it will buy Vectura Group in a deal valuing the British pharmaceutical company at 1.05 billion pounds ($1.44 billion).

Philip Morris to buy nicotine gum maker Fertin Pharma in push for smoke-free products

(Corrects paragraph 5 to say IQOS is a heated-tobacco product, not an e-cigarette brand)

Top lawyers' pay at Philip Morris, PepsiCo and Bristol Myers Squibb disclosed

It's proxy statement season again - and major companies are disclosing their top lawyers' total compensation to the U.S. Securities and Exchange Commission.

Japan Tobacco to launch new heated tobacco device later this year

Japan Tobacco Inc said on Tuesday it plans to launch a new heated tobacco device in the second half of 2021, as it tries to compete with Philip Morris' IQOS cigarettes.

Smoker's estate can hold onto $27 million in damages from Philip Morris - 11th Circ

A federal appeals court has upheld a $27 million verdict handed down more than six years ago against Philip Morris USA Inc in favor of a now-deceased woman who developed lung disease from smoking.

Louis Camilleri, Ferrari CEO and Philip Morris chairman, retires from both roles

Louis Camilleri, chief executive officer or Ferrari N.V. and executive chairman of tobacco giant Philip Morris International Inc is retiring from his roles at both companies effective immediately, the companies said on Thursday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.